Loading clinical trials...
Loading clinical trials...
A Prospective, Multi-Center, Observational Biomarker Real-World Evidence Study for In-Depth Profiling of Patients With Chronic Immune-Mediated Inflammatory Skin Diseases in Daily Practice
Conditions
Locations
8
Netherlands
Radboud University Medical Center
Nijmegen, Gelderland, Netherlands
Maastricht University Medical Center+
Maastricht, Limburg, Netherlands
Amsterdam University Medical Center
Amsterdam, North Holland, Netherlands
University Medical Center Groningen
Groningen, Provincie Groningen, Netherlands
Leiden University Medical Center
Leiden, South Holland, Netherlands
Centre for Human Drug Research
Leiden, South Holland, Netherlands
Start Date
July 29, 2025
Primary Completion Date
December 31, 2029
Completion Date
December 31, 2029
Last Updated
August 19, 2025
NCT06993233
NCT07316192
NCT07155239
NCT06592274
NCT07169019
NCT07123038
Lead Sponsor
Leiden University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions